In depth: Distinguishing a business from an asset or a group of assets (Pharmaceutical and life sciences industry)
Pharmaceutical, biotech, medical device and other life sciences companies frequently deal with the highly judgmental and complicated area of determining whether an acquisition, investment or license should be accounted for as a business combination or an asset acquisition.
Themen
Weiterlesen mit einem PwC Plus-Abonnement
- qualitätsgesicherte Quellen
- tägliche Updates
- vollständige Filterfunktion von Artikeln
- Verteilung via anpassbarem Alert
Zum Anfang
